Expertise in
3
conditions

Dr. Beth A. Carter

Pediatric Gastroenterology
Office
4650 W Sunset Blvd Fl 2, 
Los Angeles, CA 
Expertise in
3
conditions
Office
4650 W Sunset Blvd Fl 2, 
Los Angeles, CA 

Overview

Beth Carter is a Pediatric Gastroenterologist practicing medicine in Los Angeles, California.

Dr. Carter is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Short Bowel Syndrome, Biliary Atresia, Gastroschisis, and Malabsorption.

She is actively involved in clinical research, co-authoring 16 peer reviewed articles and participating in 6 clinical trials.

Specialties

Pediatric Gastroenterology

Licenses

Pediatric Gastroenterology in CA

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
LA Care
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Nippon Life
  • INSURANCE PLAN
Silversummit Health Plan
  • HMO
  • MANAGED MEDICAID PLAN
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 7 Less Insurance Carriers -

Locations

Office
4650 W Sunset Blvd Fl 2, Los Angeles, CA 90027

Additional Areas of Focus

Dr. Carter has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Phase 2b, Double-Blind, Three Arm, Randomized, Placebo Controlled Trial With Restricted Response Adaptive Randomization Testing the Efficacy and Safety of High Dose Methylprednisolone or Equine Anti-Thymocyte Globulin as Treatment for Acute Liver Failure in Pediatric Patients
A Phase 2b, Double-Blind, Three Arm, Randomized, Placebo Controlled Trial With Restricted Response Adaptive Randomization Testing the Efficacy and Safety of High Dose Methylprednisolone or Equine Anti-Thymocyte Globulin as Treatment for Acute Liver Failure in Pediatric Patients
Enrollment Status: Active_not_recruiting
Publish Date: August 12, 2026
Intervention Type: Drug
Study Drugs: Methylprednisolone, Equine anti-thymocyte globulin, Prednisolone, Diphenhydramine
Study Phase: Phase 2
A Prospective, Multi-center Registry for Patients With Short Bowel Syndrome
A Prospective, Multi-center Registry for Patients With Short Bowel Syndrome
Enrollment Status: Active_not_recruiting
Publish Date: October 10, 2025
A Prospective, Open-label, Long-term Safety and Efficacy Study of Teduglutide in Pediatric Patients With Short Bowel Syndrome Who Completed TED-C14-006 or SHP633-301
A Prospective, Open-label, Long-term Safety and Efficacy Study of Teduglutide in Pediatric Patients With Short Bowel Syndrome Who Completed TED-C14-006 or SHP633-301
Enrollment Status: Completed
Publish Date: March 28, 2025
Intervention Type: Drug, Device, Other
Study Phase: Phase 3
A Retrospective and Prospective, Open-label, Long-term Safety and Efficacy Study of Teduglutide in Pediatric Subjects With Short Bowel Syndrome Who Completed TED-C13-003
A Retrospective and Prospective, Open-label, Long-term Safety and Efficacy Study of Teduglutide in Pediatric Subjects With Short Bowel Syndrome Who Completed TED-C13-003
Enrollment Status: Completed
Publish Date: March 19, 2025
Intervention Type: Other, Drug
Study Phase: Phase 3
A 24-Week Double-blind, Safety, Efficacy, and Pharmacodynamic Study Investigating Two Doses of Teduglutide in Pediatric Subjects Through 17 Years of Age With Short Bowel Syndrome Who Are Dependent on Parenteral Support
A 24-Week Double-blind, Safety, Efficacy, and Pharmacodynamic Study Investigating Two Doses of Teduglutide in Pediatric Subjects Through 17 Years of Age With Short Bowel Syndrome Who Are Dependent on Parenteral Support
Enrollment Status: Completed
Publish Date: June 09, 2021
Intervention Type: Drug, Other
Study Phase: Phase 3
Compassionate Use of an Intravenous Fat Emulsion Comprised of Fish Oil in the Treatment of Parenteral Nutrition Induced Liver Injury in Infants
Compassionate Use of an Intravenous Fat Emulsion Comprised of Fish Oil in the Treatment of Parenteral Nutrition Induced Liver Injury in Infants
Enrollment Status: Completed
Publish Date: May 28, 2021
Intervention Type: Drug
Study Phase: Not Applicable
View 5 Less Clinical Trials

16 Total Publications

CD8 TRM-like T cells expressing perforin and IFN-γ define a pediatric activated T-cell acute liver failure endotype.
CD8 TRM-like T cells expressing perforin and IFN-γ define a pediatric activated T-cell acute liver failure endotype.
Journal: Hepatology communications
Published: December 11, 2025
Similar Doctors
Expertise in
8
conditions
Dr. Robert S. Venick
Pediatric Gastroenterology
Expertise in
8
conditions
Dr. Robert S. Venick
Pediatric Gastroenterology
Referral may be required

Office

200 Medical Plz Ste 265, 
Los Angeles, CA 
 (9.3 miles away)
310-206-6134
Languages Spoken:
English
See accepted insurances

Robert Venick is a Pediatric Gastroenterologist practicing medicine in Los Angeles, California. Dr. Venick is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Malabsorption, Short Bowel Syndrome, Alagille Syndrome, Liver Transplant, and Pancreas Transplant.

Expertise in
5
conditions
Dr. Yuhua F. Zheng
Pediatric Gastroenterology
Expertise in
5
conditions
Dr. Yuhua F. Zheng
Pediatric Gastroenterology
Referral may be required

Children's Hospital Los Angeles

4650 W Sunset Blvd, 
Los Angeles, CA 
 (2.1 miles away)
323-361-2181
Languages Spoken:
English
See accepted insurances

Yuhua Zheng is a Pediatric Gastroenterologist practicing medicine in Los Angeles, California. Dr. Zheng is highly rated in 5 conditions, according to our data. Her clinical expertise encompasses Childhood Pancreatitis, Exocrine Pancreatic Insufficiency, Hereditary Pancreatitis, Kidney Transplant, and Endoscopy.

Expertise in
6
conditions
Dr. Nisreen Soufi
Pediatric Gastroenterology
Expertise in
6
conditions
Dr. Nisreen Soufi
Pediatric Gastroenterology
Referral may be required

Children's Hospital Los Angeles

4650 W Sunset Blvd, 
Los Angeles, CA 
 (2.1 miles away)
323-669-2113
Languages Spoken:
English
See accepted insurances

Nisreen Soufi is a Pediatric Gastroenterologist practicing medicine in Los Angeles, California. Dr. Soufi is highly rated in 6 conditions, according to our data. Her clinical expertise encompasses Progressive Familial Intrahepatic Cholestasis Type 1, Biliary Atresia, Cholestasis, Small Bowel Resection, and Liver Transplant.

Frequently Asked Questions about Dr. Beth A. Carter

How do I make an appointment with Dr. Beth A. Carter?

You can book an appointment with Dr. Beth A. Carter by calling their office at 323-361-2181. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Beth A. Carter a top-rated expert for Short Bowel Syndrome?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Beth A. Carter is classified as an Distinguished expert for Short Bowel Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Beth A. Carter specialize in?

While Dr. Beth A. Carter is a Pediatric Gastroenterology, they have specific expertise in Short Bowel Syndrome, Biliary Atresia, and Gastroschisis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pediatric Gastroenterology.

Does Dr. Beth A. Carter participate in research or clinical trials?

Yes. Dr. Beth A. Carter has published 16 articles and abstracts on conditions like Short Bowel Syndrome. You can view a list of Dr. Beth A. Carter's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Beth A. Carter accept my insurance?

Dr. Beth A. Carter accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 323-361-2181 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Carter's expertise for a condition
ConditionClose
    View All 14 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile